Developer docs
API playgroundTry for free, no card

Search company profiles

Komodo Health

Full company profile

uuid00003ip

Namestring
Komodo Health
Legal namestring
Komodo Health, Inc.
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare analytics platform, real-world evidence data, patient journey analytics, healthcare AI software, life sciences intelligence
Industry4 codes
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAHAA
Value-Based Contracting Analytics (ACO/MSSP/MA, shared savings/risk)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics
NAICS code2 codes
  • Software Publishers513210
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Analytics Software
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Healthcare Analytics SaaS Platform Subscription
TypeSubscription Recurring
Description

Subscription-based access to the Healthcare Map and Marmot AI analytics platform. Includes data licensing, software access, and platform capabilities. Enterprise agreements with annual or multi-year contract terms.

komodohealth.com
2Data Licensing
TypeLicensing Royalties
Description

Licensing of de-identified healthcare data from the Healthcare Map for use in research, analytics, and evidence generation. Revenue generated through data access agreements with Life Sciences organizations, payers, and healthcare providers.

komodohealth.com
3Professional Services
TypeProfessional Services
Description

Implementation, consulting, and custom analytics services. Includes support for HEOR/RWE studies, clinical development analytics, and custom workflow development.

komodohealth.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Enterprise custom pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Annual or multi-year enterprise agreements tailored to customer requirements.

komodohealth.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 12 records shown
1Healthcare Map
Description

The industry's most comprehensive view of over 330 million de-identified patient journeys with 1 trillion+ linked records from 60+ sources, refreshed daily.

komodohealth.com
+11 more records
Core offering1 text field

Komodo Health sells a healthcare AI analytics platform built on two pillars: the Healthcare Map, a data foundation containing 1 trillion+ linked records covering 330 million+ de-identified patient journeys from 60+ sources refreshed daily, and Marmot, the company's healthcare-native AI analytics engine. The platform is sold primarily to Life Sciences, payers, financial services, and healthcare consultancies to generate auditable, reproducible insights on patient populations, treatment patterns, drug utilization, and commercial strategy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 2.3X higher accuracy vs. frontier AI models in healthcare analytics
+5 more records
Product overview1 text field

Komodo Health offers a unified platform architecture built on two core pillars: the Healthcare Map data foundation and the Marmot AI analytics engine. The Healthcare Map provides the data layer with 1 trillion+ linked records covering 330M+ de-identified patient journeys from 60+ sources. The Marmot AI platform serves as the intelligence layer, enabling plain-language queries, autonomous agent workflows, and reproducible analytical outputs. Built on top are modular applications including MapLab (no-code/low-code/high-code workflows), MapAI (conversational querying), MapExplorer (patient population exploration), MapEnhance (specialty data integration), MapView (pre-built dashboards), Clinical Alerts (predictive notifications), Drug Projections (utilization forecasting), Field Sales Insights (commercial targeting), KOL Profiling (key opinion leader identification), and Custom Analytics (tailored export). The Maven's sub-brand extends capabilities through Salesforce for medical affairs and commercialization. The platform integrates natively with Snowflake, Databricks, AWS, and Greenhouse MCP, with additional integration pathways via Salesforce through the Maven's business unit.

Product and service4 records
1Healthcare Map
CategoryData Foundation / Real-World Evidence
Description

The foundational data platform providing 1 trillion+ linked records from 330M+ de-identified patient journeys across 60+ sources, refreshed daily. Characterized, normalized, deduplicated, certified, and analysis-ready. Includes open and closed claims data with longitudinal visibility. Sold to Life Sciences, payers, financial services, and consultancies.

2Marmot
CategoryAI Analytics Platform
Description

The healthcare-native AI analytics platform that delivers transparent, verifiable, auditable insights from the Healthcare Map. Shows its work with traceable methodology, reproducible results, and evaluation gates. Outperforms frontier AI models with 2.3X higher accuracy in healthcare analytics. Enables plain-language querying, custom AI agents, and multi-step analytical workflows for Life Sciences, payers, and financial services organizations.

3MapLab Enterprise
CategoryAnalytics Environment
Description

Enterprise-grade analytics environment offering no-code, low-code, and high-code workflows that empower any user level across organizations to explore patient populations, treatment patterns, and care journeys. Sold to large multi-team organizations.

4Mavens
CategoryEnterprise Software Services
Description

Business unit delivering global enterprise software and services on Salesforce for medical affairs, commercialization, and patient engagement. Led by Chief Business Officer Adam Tong.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-25
Description

Expanded strategic partnership to scale Marmot AI analytics platform across Alnylam's enterprise functions beyond initial commercial business focus. Alnylam reports reduced reporting cycles from months to hours and eliminated reliance on fragmented dashboards. Expansion reflects broader industry shift toward enterprise-wide AI adoption in Life Sciences.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-03-04
Description

Partnership to improve prostate cancer screening and care through AI-enabled insights, focusing on underserved communities. Leverages Healthcare Map AI platform to identify gaps in care and inform policy and community efforts. Initiative aims to close disparities and save 100,000 lives by 2035.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-08
Description

Strategic partnership to build world's most comprehensive longitudinal rare disease dataset by integrating GeneDx Infinity genomic platform (2.5M+ genetic tests, 7M phenotypic data points) with Komodo's Healthcare Map (330M+ de-identified patients). Supports health economics research, biopharma R&D, clinical trials, market access, and AI-driven discovery using privacy-preserving methodologies.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-02
Description

Healthcare Map integration on Snowflake for advanced analytics. Provides thousands of data-driven organizations seamless access to de-identified healthcare data within Snowflake environment through marketplace listing.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-10-20
Description

Collaboration analyzing metastatic breast cancer care revealing dual reality of ADC treatment adoption and age-related disparities. Analysis found ADC treatment rates increased 3.7-fold while women 66+ faced rates 3.4x lower than younger patients.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-09-21
Description

Partnership on Alzheimer's research analyzing screening and treatment patterns. Analysis found cognitive screening up 10%, biomarker testing up 23%, while Black patients accounted for only 3% of those treated despite making up 10% of patient population.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-07-23
Description

Strategic partnership to unleash next-generation healthcare AI and revolutionize clinical development through combined capabilities.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-05-06
Description

Partnership to deliver first integrated healthcare-specialized data insights to financial services industry. Enables hedge funds, private equity, and venture capital firms to make more informed investment decisions with insights from Komodo's Healthcare Map covering 330M+ patient journeys.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-04-17
Description

Expanded partnership to deliver real-time access to healthcare data through Delta Sharing. Enables seamless data access within Databricks environment for analytics and AI applications.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-01-13
Description

Partnership combining Helix's clinico-genomic datasets with Komodo's Healthcare Map for enhanced clinical and research impact. Integrates genomic insights with real-world patient journey data.

Strategic tierAcquisitionTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-07-27
Description

Acquisition of Breakaway Partners, a market access software company, to develop enterprise market access solution combining real-world patient data with formulary and policy insights. Extended Komodo's data and software offerings across healthcare ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veradigm combines electronic health record data with life sciences analytics offerings; comparable to Komodo's provider-side data and clinical research use cases, though distributed through a much broader EHR and analytics portfolio.

TypeEmerging player
Description

Datavant provides a healthcare data connectivity and de-identification layer enabling record linkage across data sources; comparable to the data-fabric layer underneath Komodo's Healthcare Map and increasingly a partner/competitor in RWD assembly.

TypeDirect peer
Description

Flatiron Health (a Roche subsidiary) operates an oncology-specific real-world data and analytics platform used by life sciences for research and commercial analytics; directly comparable to Komodo's life sciences RWD analytics offering with similar data-and-software go-to-market.

4Tempus AI
TypeEmerging player
Description

Tempus AI combines multimodal clinical and genomic data with AI for precision medicine and life sciences research; overlaps with Komodo on AI-driven healthcare analytics and genomic data integration, though Tempus is earlier-stage in commercialization.

TypeDirect peer
Description

ConcertAI provides AI-driven real-world evidence and clinical trial solutions focused on oncology and specialty therapeutics; competes directly with Komodo in life sciences RWE and clinical development analytics.

6HealthVerity
TypeEmerging player
Description

HealthVerity assembles de-identified patient-level data from 150+ sources and licenses it for pharma and payer analytics; competes with Komodo's Healthcare Map data offering, particularly for closed claims and specialty data licensing.

TypeDirect peer
Description

TriNetX operates a global real-world data network for clinical trial design, protocol optimization, and real-world evidence generation; competes head-to-head with Komodo's clinical development and RWE analytics use cases across pharma customers.

TypeEmerging player
Description

Aetion delivers a real-world evidence analytics platform for regulatory-grade studies used by pharma and regulators; directly comparable to Komodo's RWE analytics use case but with a narrower data foundation and software-first focus.

TypeBroad incumbent
Description

IQVIA is the largest global real-world evidence and life sciences analytics provider with deep claims data, clinical trial services, and pharma relationships; Komodo competes for the same pharma/biotech analytics budget but at smaller scale and only in the U.S.

TypeBroad incumbent
Description

Optum operates one of the largest U.S. healthcare data and analytics businesses tied to UnitedHealth's payer and provider footprint; competes with Komodo for payer analytics and indirectly for life sciences RWE through its scale advantages.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile7 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature15 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Komodo Health

Healthcare Analytics Softwarekomodohealth.com

Komodo Health firmographics

Firmographics
Name
Komodo Health
Legal name
Komodo Health, Inc.
Website
https://komodohealth.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Komodo Health industry classification

Industry
Product category
Healthcare Analytics Software
NAICS
Software Publishers (513210), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAHAA
Value-Based Contracting Analytics (ACO/MSSP/MA, shared savings/risk)
Healthcare & Life Sciences/Digital Health & Health IT/Population Health Management & Value-Based Care Analytics

Keywords

  • Healthcare analytics platform
  • Real-world evidence data
  • Patient journey analytics
  • Healthcare AI software
  • Life sciences intelligence

Where Komodo Health is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Komodo Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Healthcare Analytics SaaS Platform Subscription: Subscription-based access to the Healthcare Map and Marmot AI analytics platform. Includes data licensing, software access, and platform capabilities. Enterprise agreements with annual or multi-year contract terms.
  2. Data Licensing: Licensing of de-identified healthcare data from the Healthcare Map for use in research, analytics, and evidence generation. Revenue generated through data access agreements with Life Sciences organizations, payers, and healthcare providers.
  3. Professional Services: Implementation, consulting, and custom analytics services. Includes support for HEOR/RWE studies, clinical development analytics, and custom workflow development.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise custom pricing

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Komodo Health product offering

Product offering

Core offering

Komodo Health sells a healthcare AI analytics platform built on two pillars: the Healthcare Map, a data foundation containing 1 trillion+ linked records covering 330 million+ de-identified patient journeys from 60+ sources refreshed daily, and Marmot, the company's healthcare-native AI analytics engine. The platform is sold primarily to Life Sciences, payers, financial services, and healthcare consultancies to generate auditable, reproducible insights on patient populations, treatment patterns, drug utilization, and commercial strategy.

Product overview

Komodo Health offers a unified platform architecture built on two core pillars: the Healthcare Map data foundation and the Marmot AI analytics engine. The Healthcare Map provides the data layer with 1 trillion+ linked records covering 330M+ de-identified patient journeys from 60+ sources. The Marmot AI platform serves as the intelligence layer, enabling plain-language queries, autonomous agent workflows, and reproducible analytical outputs. Built on top are modular applications including MapLab (no-code/low-code/high-code workflows), MapAI (conversational querying), MapExplorer (patient population exploration), MapEnhance (specialty data integration), MapView (pre-built dashboards), Clinical Alerts (predictive notifications), Drug Projections (utilization forecasting), Field Sales Insights (commercial targeting), KOL Profiling (key opinion leader identification), and Custom Analytics (tailored export). The Maven's sub-brand extends capabilities through Salesforce for medical affairs and commercialization. The platform integrates natively with Snowflake, Databricks, AWS, and Greenhouse MCP, with additional integration pathways via Salesforce through the Maven's business unit.

Differentiator

Problem solved

Functional benefit

Brands

  • Healthcare Map: The industry's most comprehensive view of over 330 million de-identified patient journeys with 1 trillion+ linked records from 60+ sources, refreshed daily.
  • Marmot
  • MapLab Enterprise
  • MapExplorer
  • MapEnhance
  • MapAI
  • MapView
  • Drug Projections
  • Field Sales Insights
  • Clinical Alerts
  • Custom Analytics
  • KOL Profiling

Products and services

  • Healthcare Map The foundational data platform providing 1 trillion+ linked records from 330M+ de-identified patient journeys across 60+ sources, refreshed daily. Characterized, normalized, deduplicated, certified, and analysis-ready. Includes open and closed claims data with longitudinal visibility. Sold to Life Sciences, payers, financial services, and consultancies.
  • Marmot The healthcare-native AI analytics platform that delivers transparent, verifiable, auditable insights from the Healthcare Map. Shows its work with traceable methodology, reproducible results, and evaluation gates. Outperforms frontier AI models with 2.3X higher accuracy in healthcare analytics. Enables plain-language querying, custom AI agents, and multi-step analytical workflows for Life Sciences, payers, and financial services organizations.
  • MapLab Enterprise Enterprise-grade analytics environment offering no-code, low-code, and high-code workflows that empower any user level across organizations to explore patient populations, treatment patterns, and care journeys. Sold to large multi-team organizations.
  • Mavens Business unit delivering global enterprise software and services on Salesforce for medical affairs, commercialization, and patient engagement. Led by Chief Business Officer Adam Tong.

Quantifiable outcome

  • 2.3X higher accuracy vs. frontier AI models in healthcare analytics
  • +5 more outcomes

Companies that use Komodo Health

Customer profile

Named customers10 records

Segments7 records

Ideal customer profiles7 records

Komodo Health technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability9 records

Feature15 records

Komodo Health partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, strategic and acquisition.

  • Alnylam PharmaceuticalscoreStrategic or Co-development Partner · 25 June 2026Expanded strategic partnership to scale Marmot AI analytics platform across Alnylam's enterprise functions beyond initial commercial business focus. Alnylam reports reduced reporting cycles from months to hours and eliminated reliance on fragmented dashboards. Expansion reflects broader industry shift toward enterprise-wide AI adoption in Life Sciences.
  • ZERO Prostate CancerstrategicStrategic or Co-development Partner · 4 March 2026Partnership to improve prostate cancer screening and care through AI-enabled insights, focusing on underserved communities. Leverages Healthcare Map AI platform to identify gaps in care and inform policy and community efforts. Initiative aims to close disparities and save 100,000 lives by 2035.
  • GeneDxcoreStrategic or Co-development Partner · 8 January 2026Strategic partnership to build world's most comprehensive longitudinal rare disease dataset by integrating GeneDx Infinity genomic platform (2.5M+ genetic tests, 7M phenotypic data points) with Komodo's Healthcare Map (330M+ de-identified patients). Supports health economics research, biopharma R&D, clinical trials, market access, and AI-driven discovery using privacy-preserving methodologies.
  • SnowflakecoreTechnology or Integration · 2 November 2025Healthcare Map integration on Snowflake for advanced analytics. Provides thousands of data-driven organizations seamless access to de-identified healthcare data within Snowflake environment through marketplace listing.
  • Tigerlily FoundationstrategicStrategic or Co-development Partner · 20 October 2025Collaboration analyzing metastatic breast cancer care revealing dual reality of ADC treatment adoption and age-related disparities. Analysis found ADC treatment rates increased 3.7-fold while women 66+ faced rates 3.4x lower than younger patients.
  • Medscape EducationstrategicStrategic or Co-development Partner · 21 September 2025Partnership on Alzheimer's research analyzing screening and treatment patterns. Analysis found cognitive screening up 10%, biomarker testing up 23%, while Black patients accounted for only 3% of those treated despite making up 10% of patient population.
  • Anervea.aistrategicStrategic or Co-development Partner · 23 July 2025Strategic partnership to unleash next-generation healthcare AI and revolutionize clinical development through combined capabilities.
  • NasdaqstrategicStrategic or Co-development Partner · 6 May 2025Partnership to deliver first integrated healthcare-specialized data insights to financial services industry. Enables hedge funds, private equity, and venture capital firms to make more informed investment decisions with insights from Komodo's Healthcare Map covering 330M+ patient journeys.
  • DatabrickscoreTechnology or Integration · 17 April 2025Expanded partnership to deliver real-time access to healthcare data through Delta Sharing. Enables seamless data access within Databricks environment for analytics and AI applications.
  • HelixstrategicStrategic or Co-development Partner · 13 January 2025Partnership combining Helix's clinico-genomic datasets with Komodo's Healthcare Map for enhanced clinical and research impact. Integrates genomic insights with real-world patient journey data.
  • Breakaway PartnersacquisitionOEM/ Whitelabel/ Licensing Partner · 27 July 2021Acquisition of Breakaway Partners, a market access software company, to develop enterprise market access solution combining real-world patient data with formulary and policy insights. Extended Komodo's data and software offerings across healthcare ecosystem.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Komodo Health competitors and assessment

Company assessment

Broad incumbents

  • Veradigm (formerly Allscripts): Veradigm combines electronic health record data with life sciences analytics offerings; comparable to Komodo's provider-side data and clinical research use cases, though distributed through a much broader EHR and analytics portfolio.
  • IQVIA: IQVIA is the largest global real-world evidence and life sciences analytics provider with deep claims data, clinical trial services, and pharma relationships; Komodo competes for the same pharma/biotech analytics budget but at smaller scale and only in the U.S.
  • Optum (UnitedHealth Group): Optum operates one of the largest U.S. healthcare data and analytics businesses tied to UnitedHealth's payer and provider footprint; competes with Komodo for payer analytics and indirectly for life sciences RWE through its scale advantages.

Emerging players

  • Datavant: Datavant provides a healthcare data connectivity and de-identification layer enabling record linkage across data sources; comparable to the data-fabric layer underneath Komodo's Healthcare Map and increasingly a partner/competitor in RWD assembly.
  • Tempus AI: Tempus AI combines multimodal clinical and genomic data with AI for precision medicine and life sciences research; overlaps with Komodo on AI-driven healthcare analytics and genomic data integration, though Tempus is earlier-stage in commercialization.
  • HealthVerity: HealthVerity assembles de-identified patient-level data from 150+ sources and licenses it for pharma and payer analytics; competes with Komodo's Healthcare Map data offering, particularly for closed claims and specialty data licensing.
  • Aetion: Aetion delivers a real-world evidence analytics platform for regulatory-grade studies used by pharma and regulators; directly comparable to Komodo's RWE analytics use case but with a narrower data foundation and software-first focus.

Direct peers

  • Flatiron Health: Flatiron Health (a Roche subsidiary) operates an oncology-specific real-world data and analytics platform used by life sciences for research and commercial analytics; directly comparable to Komodo's life sciences RWD analytics offering with similar data-and-software go-to-market.
  • ConcertAI: ConcertAI provides AI-driven real-world evidence and clinical trial solutions focused on oncology and specialty therapeutics; competes directly with Komodo in life sciences RWE and clinical development analytics.
  • TriNetX: TriNetX operates a global real-world data network for clinical trial design, protocol optimization, and real-world evidence generation; competes head-to-head with Komodo's clinical development and RWE analytics use cases across pharma customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Komodo Health social profiles

Digital presence

Komodo Health compliance and trust

Trust signal

Compliance2 records

Komodo Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Komodo Health leadership team

Management profile

Number of profiles

Profiles11 records

Komodo Health subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Komodo Health funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Komodo Health M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Komodo Health

What does Komodo Health do?

Komodo Health sells a healthcare AI analytics platform built on two pillars: the Healthcare Map, a data foundation containing 1 trillion+ linked records covering 330 million+ de-identified patient journeys from 60+ sources refreshed daily, and Marmot, the company's healthcare-native AI analytics engine. The platform is sold primarily to Life Sciences, payers, financial services, and healthcare consultancies to generate auditable, reproducible insights on patient populations, treatment patterns, drug utilization, and commercial strategy.

Is Komodo Health a public or private company?

Komodo Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Komodo Health founded?

Komodo Health was founded in 2015. It employs 501 to 1,000 people.

Where is Komodo Health based?

Komodo Health is headquartered in New York, United States, in the North America region.

How does Komodo Health make money?

Three revenue lines are on record. Healthcare Analytics SaaS Platform Subscription is the primary driver. The others are data Licensing and professional Services.

Who are Komodo Health's main competitors?

Broad incumbents on record are Veradigm (formerly Allscripts), IQVIA and Optum (UnitedHealth Group). Emerging players are Datavant, Tempus AI, HealthVerity and Aetion. Direct peers are Flatiron Health, ConcertAI and TriNetX.

Does Komodo Health have an API?

Yes. Marmot Development Kit enables direct access to the Healthcare Map within Snowflake, Databricks, or Python environments. Users can query cohorts, power ML models, and run AI agents without data exports. Komodo's platform also offers integration through AWS Marketplace for deployment. Developer documentation is at www.komodohealth.com/product/updates.

What industry is Komodo Health in?

Komodo Health's product category is Healthcare Analytics Software. Its primary akta.pro industry code is HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D), with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HLTHKomodo Health and NCQA Partner to Advance Healthcare Quality MeasurementKomodo Health and NCQA launched a multiyear collaboration to develop healthcare quality measures using AI analytics and real-world data. The partnership aims to cut testing time from two to three months to about one month, with a new colonoscopy measure expected in 2027.Healthcare IT NewsKomodo Health, NCQA partner to accelerate healthcare quality measurementKomodo Health and NCQA launched a multiyear collaboration to accelerate development and refinement of HEDIS quality measures using real-world data and AI analytics. The partnership will use Komodo's Healthcare Map, covering over 330 million de-identified patient journeys, and Marmot AI platform. A new colorectal cancer follow-up measure is scheduled for implementation in 2027.ModernhealthcareNCQA, Komodo Health partner on HEDIS measures - Modern HealthcareThe National Committee for Quality Assurance is partnering with artificial intelligence company Komodo Health to test new quality measures. The collaboration aims to develop HEDIS measures using AI technology.MobiHealthNewsKomodo Health, NCQA partner to accelerate healthcare quality measurementKomodo Health and the National Committee for Quality Assurance announced a multiyear collaboration to speed the development, validation and refinement of healthcare quality measures, using Komodo's Healthcare Map covering over 330 million de-identified patient journeys and its Marmot AI analytics platform. The pair tested a colorectal cancer follow-up HEDIS measure in about one month, versus two to three months historically, with implementation scheduled for 2027.FierceHealthcareNCQA to use Komodo data, AI tool to develop future HEDIS measuresKomodo Health, an AI-powered healthcare intelligence company, has entered a multi-year partnership with the National Committee for Quality Assurance to support HEDIS measure development. NCQA researchers will access Komodo's Healthcare Map, covering over 330 million de-identified patient journeys, and its Marmot AI platform. NCQA said the partnership cut testing time nearly in half, from two to three months to about a month.01netKomodo Health and NCQA Collaborate to Accelerate the Future of Healthcare Quality MeasurementKomodo Health and NCQA announced a multi-year collaboration to modernize healthcare quality measure development using real-world data and AI. The partnership accelerated testing of a new HEDIS measure, COF-E, from two to three months to about a month. NCQA will continue using Komodo's capabilities for additional HEDIS measures.ModernhealthcareNCQA, Komodo Health partner on HEDIS measures - Modern HealthcareThe National Committee for Quality Assurance announced a partnership with artificial intelligence company Komodo Health to test new quality measures. The article notes that over 236 million patients are enrolled in insurance plans using NCQA's Healthcare Effectiveness Data and Information Set. No financial terms or timelines were disclosed.Tracxn2026 Funding Rounds & List of InvestorsKomodo Health has raised $514M across five funding rounds, with its largest being a $220M Series E in March 2021. The company has 16 institutional investors, including Andreessen Horowitz and Coatue, with the most recent round in November 2022.BioSpaceAlnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period ProgressAlnylam reported Q2 2026 net product revenues of $1.172 billion, up 74% year-over-year, driven by $1.030 billion in TTR revenues. The company revised its full-year 2026 TTR net product revenue guidance down to $4.2–4.5 billion, citing normalized second-line demand. It also advanced pipeline programs and entered a China commercialization agreement.YahooIs Rival ATTR-CM Trial Failure and New AI Deals Altering The Investment Case For Alnylam (ALNY)?AstraZeneca and Ionis announced the late-stage failure of their competing ATTR cardiomyopathy trial, a development that strengthens Alnylam Pharmaceuticals' competitive position in the TTR franchise market. Alnylam simultaneously expanded its Marmot AI partnership with Komodo Health to enhance real-time data analytics across commercial operations, particularly for ATTR-CM patient identification and market access in European markets. The article examines investor projections of Alnylam reaching $9.0 billion in revenue and $2.0 billion in earnings by 2029, contingent on managing AMVUTTRA net pricing and gross margin pressures alongside sustaining 28.3% annual revenue growth.